Dr. Vorobiof on the Impact of Financial Toxicity in the Field of Oncology – Part 2

December 2020.

Daniel A. Vorobiof, MD, the chief medical director of Belong.Life, discusses the impact of financial toxicity on patients with cancer.

Financial toxicity has become a growing concern for several patients with cancer, as well as their caregivers, says Vorobiof. As treatment costs continue to rise, Vorobiof says that financial toxicity is a challenge that can no longer be ignored. A cancer diagnosis is often accompanied by substantial financial burden, and although this is not a new issue, it must be addressed, Vorobiof says.

Real-world data from several clinical studies indicate that financial toxicity is a major factor that impacts outcomes and the quality of life of patients, spanning different tumor types and treatments received, Vorobiof concludes.

Watch Now >

More Articles
Global web icon

Inside the Making of a Patient-Centric Cancer AI Mentor

Belong.Life developed Dave, its AI cancer mentor, with direct input from real patients, caregivers, and…
Global web icon

Patient Engagement Boosted by Belong.Life AI Mentors and Equiva platforms

US-based Equiva and Belong.Life have entered a partnership to integrate Belong’s conversational AI mentors into…
Global web icon

Belong.Life and Equiva bring AI mentors to healthcare providers

Strategic Partnership Overview Belong.life, the GenAI patient engagement solution, has announced a strategic partnership with Equiva,…
Skip to content